ARCHIVES

AACR Urges FDA To Speed Approval of Therapies for Precancerous Lesions

This article is from The Cancer Letter archive.

Vol. 28 No. 42 | November 15, 2002

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

In Brief: Former Oklahoma Re. Synar, Opponent of Tobacco, dead at 45 Of Brain Cancer

January 12, 1996

GSK Vaccine Prevents Lesions Associated With HPV

July 28, 2006

In Brief: Cancer Panel To Meet Aug.29; RFP On Impact Of Planning Cancelled As Being “Premature“

August 15, 1980

Administration Asking $233 Million Less For NCI In FY ’88 Than Congress Is Appropriating For ‘87

October 10, 1986

First NCAB “Road” Hearing In L.A.

September 18, 1987